tm logo
COVALFINDER
Live/Registered
REGISTERED

on 17 Oct 2023

Last Applicant/ Owned by

Parque Científico de Madrid C/ Santiago

Madrid

ES

E-28760

Serial Number

97053441 filed on 30th Sep 2021

Registration Number

7191864 registered on 17th Oct 2023

in the Principal Register

Correspondent Address

Tristan A. Fuierer

Tristan A. Fuierer

2275 Deming Way, Suite #310

Middleton, WI 53562

Filing Basis

No Filing Basis

Disclaimer

NO DATA

COVALFINDER

Science and technology services, namely, research and design in the field of pharmaceutical and biotechnology industries; Technical research in the field of pharmaceutical and biotechnology studies; Scientific services and design relating thereto; Technological consulting services and engineering design relating thereto; Scientific research; Industrial analysis and research services in the field o Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Science and technology services, namely, research and design in the field of pharmaceutical and biotechnology industries; Technical research in the field of pharmaceutical and biotechnology studies; Scientific services and design relating thereto; Technological consulting services and engineering design relating thereto; Scientific research; Industrial analysis and research services in the field of pharmaceuticals and biotechnology; Software design and development; Design and development of computer hardware; Mathematical research services; Computer software creation; Installation of computer software; Computer software research; Software development; Computer programming services for others in the field of software configuration management; Computer software design; Updating of computer software; Software engineering; All the aforesaid services being limited to the pharmaceutical and biotechnology industries; None of the foregoing including and all of the foregoing excluding services relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Class [009]
Computer & Software Products & Electrical & Scientific Products


Recorded software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded science software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded bioinformatics software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded computer software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Embedded software for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; Recorded computer software packages for use in data analysis, data generation or database management in the pharmaceutical and biotechnology industries; All the aforesaid software being limited to the pharmaceutical and biotechnology industries; None of the foregoing including and all of the foregoing excluding software and products relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Mark Details


Serial Number

No 97053441

Mark Type

No Service Mark

Attorney Docket Number

No 40406.201

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Oct 2023REGISTERED-PRINCIPAL REGISTER
17th Oct 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
10th Sep 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
29th Aug 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
28th Aug 2023ASSIGNED TO PETITION STAFF
10th Aug 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
01st Jun 2023EXTENSION OF TIME TO OPPOSE RECEIVED
02th May 2023PUBLISHED FOR OPPOSITION
02th May 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Apr 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED